Previous News Items

New Poster Presentation. "A Superior New Disulfide Support for Oligonucleotide Synthesis" This poster provides an overview of our Thiol-modifier-oxa-6-S-S CPG as it compares to other disulfide modifiers. The poster presented at the 10^th Winter Conference on Medicinal and Bioorganic Chemistry, January 2011.

Supply Agreement with Applied Biosystems announced (July 29, 2008) to supply a key reagent for Applied Biosystems' genomic analysis system, the SOLiD System.  Press release

Collaboration with Luminos, LLC announced (Jan. 8, 2008) in order to develop luminescent assay kits. Press release

Fall, 2006-- Volume 1, issue 2 of "Chemistry from Berry & Associates" published, featuring new RNA phosphoramidites, QUAL probes, a probe for phytase activity, and much more.

April 5, 2006-- Berry & Associates awarded $749k Phase II SBIR grant for oligonucleotide purification method.

December 1, 2005 -- Berry & Associates has acquired several rare nucleosides,e.g.,

• showdomycin
• formycin A
• formycin B
• pseudouridine
• pyrazofurin
• toyocamycin
• tubercidin
• allopurinol riboside
• 5-iodotubercidin

Gram quantities are available but supplies are limited.

February 8, 2005 -- Berry & Associates announces a licensing agreement with Fluorous Technologies, Inc. (FTI), which provides Berry & Associates and its customers access to FTI's proprietary fluorous separation technology.

Copyright © 2007, Berry & Associates Inc. All rights reserved.